| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
TherapeuticsMD (NASDAQ:TXMD) reported $784.000 thousand in sales this quarter. This is a 43.33 percent increase over sales of $...
TherapeuticsMD (NASDAQ:TXMD) reported quarterly earnings of $0.05 per share. This is a 155.56 percent increase over losses of $...
TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(...